Ventricular Dysfunction, Right: Clinical Trials

3 trials for Ventricular Dysfunction, Right, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 unknown. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 2, Unknown 1
Phase 22Terminated 1, Unknown 1

Follow Ventricular Dysfunction, Right: new trials by email Literature Review of Ventricular Dysfunction, Right trials Research Report on Ventricular Dysfunction, Right

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV
levosimendan, 5% glucose injection - Transesophageal Echocardiography, Acute Respiratory Distress Syndrome
Phase 2 / Phase 3UnknownUnion Hospital, Tongji Medical College, Huazhong University of Science and Technology582023-03-222023-03-14
Catheter-Directed Thrombolysis Versus Anticoagulation Monotherapy in Intermediate-High Risk PE
Conventional catheter-directed thrombolysis (CDT) with recombinant tissue plasminogen activator (rtPA), Enoxaparin - Pulmonary Embolism, Pulmonary Thromboembolisms
Phase 3TerminatedRajaie Cardiovascular Medical and Research Center942018-12-222021-12-29
Diclofenac for Submassive PE
Diclofenac, Placebo - Pulmonary Embolism
Phase 2 / Phase 3TerminatedMinistry of Health, Spain342012-05-012017-09-06

Narrower conditions

Pulmonary Embolism (2)  ·  Inflammation (1)  ·  Respiratory Distress Syndrome (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Lung Diseases (3)  ·  Respiratory Tract Diseases (3)  ·  Ventricular Dysfunction (3)  ·  Embolism (2)  ·  Embolism and Thrombosis (2)  ·  Vascular Diseases (2)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiration Disorders (1)

Interventions

Diclofenac (1)  ·  Enoxaparin (1)  ·  Glucose (1)  ·  Heparin, Low-Molecular-Weight (1)  ·  Simendan (1)  ·  carbohydrate-deficient transferrin (1)

Sponsors

Ministry of Health, Spain (1)  ·  Rajaie Cardiovascular Medical and Research Center (1)  ·  Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)

Countries

China (1)  ·  Iran (1)  ·  Spain (1)

Top investigators

David Jimenez, MD, PhD (1)  ·  Parham Sadeghipour, M.D (1)

Results publications

PMID 29247809, PMID 36260302